% | $
Quotes you view appear here for quick access.

Trius Therapeutics, AŞ Message Board

  • raysfrom98 raysfrom98 Jun 12, 2013 10:12 AM Flag

    Todays news will be followed by a new round of institutional buying.

    IMO , so get in while its cheap.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 8:06AM Trius Therapeutics announces publication of antibiotic safety study in antimicrobial agents and chemotherapy; results suggest no clinically significant interactions between co's experimental antibiotic tedizolid and a commonly used class of medications (TSRX) 8.74 : Co announced the publication of the results of multiple clinical and animal studies showing the company's experimental antibiotic, tedizolid phosphate (TR-701), does not interact with monamine oxidase. MAO is an enzyme involved in the regulation of neurotransmitters such as serotonin, norepinephrine and dopamine, and its inhibition can lead to serious drug-drug interactions. These results were published in the July 2013 print issue of Antimicrobial Agents and Chemotherapy